MedPath

Reliability of EEG, ERP and eye tracking measurements in infants

Completed
Conditions
n.v.t.
Registration Number
NL-OMON40656
Lead Sponsor
niversiteit Utrecht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
75
Inclusion Criteria

• Age 10 months old (± 4 weeks; at time of testing)
• Born fullterm (>37)

Exclusion Criteria

• Infant was premature (pre 37 weeks)
• Infant is looked after by the state (e.g. foster care), or other situation in which neither birth parent is involved in the infant*s care.
• Presence of known significant uncorrected vision or hearing impairment in infant (reported to parent by a doctor or health professional)
• Presence of known significant developmental or medical condition in infant likely to affect brain development or infant*s ability to participate in the study (e.g. Cerebral Palsy, Down*s syndrome, cystic fibrosis; reported to parent by a doctor or health professional)

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Our evaluation of the test-retest reliability of measures of brain development<br /><br>will be based on the following outcomes:<br /><br>- ERP peaks related to face processing in infants, specifically the amplitude<br /><br>and latency of the so-called N290 peak, in response to photographs of faces<br /><br>with different emotional expressions (emotional face task).<br /><br>- Background EEG, as reflected in power in specific frequency bands in the EEG,<br /><br>especially gamma power, to social and nonsocial film videos (background EEG<br /><br>task)<br /><br>- Length and number of visual fixations to stimuli that test different stages<br /><br>of attention (gap/overlap task).</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>None</p><br>
© Copyright 2025. All Rights Reserved by MedPath